StockData
Processa Pharmaceuticals, Inc. logo

Processa Pharmaceuticals, Inc. (PCSA) stock

PCSANasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 4/30
$1.73+0.01 (+0.58%)

Close on Nov 17, 2026Market cap $4.83MP/E –Yield –

Processa Pharmaceuticals profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Processa Pharmaceuticals's profit margin for the twelve months ending Dec 31, 2016 was -38341.3%. For fiscal 2016 it was -38341.3%, against -2957.2% the year before. The highest annual figure on record is -982.0% in fiscal 2013.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2016Dec 31, 2016-38341.3%−35384.1
FY2015Dec 31, 2015-2957.2%+1263.5
FY2014Dec 31, 2014-4220.7%−3238.7
FY2013Dec 31, 2013-982.0%+288.1
FY2012Dec 31, 2012-1270.2%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q1 FY2016Mar 31, 2016-5619.0%–

More Processa Pharmaceuticals figures

See a number that looks wrong?